גונאל-אף 75 יחידות בינל (5.5 מקג)

Land: Israël

Taal: Hebreeuws

Bron: Ministry of Health

Werkstoffen:

FOLLITROPIN ALFA

Beschikbaar vanaf:

MERCK SERONO LTD

ATC-code:

G03GA05

farmaceutische vorm:

אבקה להכנת תמיסה לזריקה

Samenstelling:

FOLLITROPIN ALFA 5.5 MCG/DOSE

Toedieningsweg:

תוך-שרירי, תת-עורי

Prescription-type:

מרשם נדרש

Geproduceerd door:

MERCK SERONO S.A., SWITZERLAND

Therapeutische categorie:

FOLLITROPIN ALFA

Therapeutisch gebied:

FOLLITROPIN ALFA

therapeutische indicaties:

1) Gonal-F followed by chorionic gonadotrophin (hCG) is recommended for the stimulation of follicular development and ovulation in women with hypothalamic-pituitary dysfunction who present with either oligomenorrhoea or amenorrhoea. These women are classified as W.H.O group II patients and usually receive clomiphene citrate as primary therapy. They have evidence of endogenous oestrogen production and thus will either spontaneously menstruate or experience withdrawal bleeding after progestagen administration. Polycystic ovarian disease (PCOD) is part of the WHO II classification and is present in the majority of these patients. 2) Gonal-F is indicated for stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertillization (IVF) gamete intra-fallopian transfer (GIFT) and zogote intra-fallopian transfer (ZIFT). 3) Gonal-F is indicated with concomitant human chorionic gonadotrophin (HCG) therapy for the stimulation of sperma

Autorisatie datum:

2017-12-31